Table 1. RNA oligonucleotide sequences employed in the crystallization trials.
| Code | Length | 5′→3′ sequence |
|---|---|---|
| SC | 15 | GGA CUG AUC AGU CCA |
| Y | 15 | CAC UUG ACC UGG CUC |
| R | 15 | GAG CCA GGU CAA GUG |
| Y1 | 17 | G CAC UUG ACC UGG CUC G |
| R1 | 17 | C GAG CCA GGU CAA GUG C |
| Y2 | 16 | G CAC UUG ACC UGG CUC |
| R2 | 16 | C GAG CCA GGU CAA GUG |
| Y3 | 16 | CAC UUG ACC UGG CUC G |
| R3 | 16 | GAG CCA GGU CAA GUG C |
| Y4 | 9 | CCU GGC UCG |
| R4 | 9 | CGA GCC AGG |
| Y5 | 9 | CUG GCU CGC |
| R5 | 9 | GCG AGC CAG |
| Y6 | 10 | GCA CUU GAC C |
| R6 | 10 | GGU CAA GUG C |